National Cancer Institute, Naples
Clinical trials sponsored by National Cancer Institute, Naples, explained in plain language.
-
New vaccine combo aims to stop liver cancer return
Disease control OngoingThis early-phase trial tests a cancer vaccine (IMA970A) plus an immunotherapy drug (durvalumab) in about 10 people with very early to intermediate liver cancer who have already had standard treatments. The goal is to see if the combination is safe and can help lower the chance of…
Phase: PHASE1 • Sponsor: National Cancer Institute, Naples • Aim: Disease control
Last updated May 13, 2026 16:04 UTC
-
New hope for prostate cancer patients: can erectile function be restored?
Symptom relief OngoingThis study looks at whether men with prostate cancer can regain erectile function and improve quality of life after stopping hormone therapy and receiving radiotherapy. About 50 men will take a hormone drug (Relugolix) followed by radiation, then fill out questionnaires on sexual…
Phase: PHASE2 • Sponsor: National Cancer Institute, Naples • Aim: Symptom relief
Last updated May 15, 2026 11:55 UTC